Clinical Practice Guideline - Ce4less

NSAID + Pred [bridge Rx until DMARDS take effect, slows radiology progression, active synovitis], + MTx [contraindicated in hepatic – 1/100 severe fibrosis Aus study 1994, renal, lung disease – bilateral alveolar infiltrates, hypoxia, decr DLCO, Rx pneumonitis pred 60mg 2-4/52 noting majority recover completely; those who can’t stop EtOH, LFTs monitored 1-3/12, use folic acid, risk of ... ................
................